Effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate on the physical properties of arterial walls in high cholesterol diet-fed rabbits.
The effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate (EPA-E) on in vivo physical properties of arteriosclerotic aorta and femoral artery in high cholesterol diet (HCD)-fed rabbits were studied. The aortic pulse wave velocity (PWV) of rabbits fed HCD for 12 weeks (control group) tended to be higher than that of rabbits fed a normal diet (normal group). Because the PWVs in HCD-fed rabbits administered orally with 30 and 300 mg/kg/day EPA-E were significantly lower than the PWV of the control group, the distensibility of arteriosclerotic aorta was improved with administration of EPA-E. The stiffness parameter (beta) value as an in vivo indicator of arteriosclerosis was significantly higher in the control group than in the normal group and improved with administration of EPA-E to almost the same level as that of the normal group. The beta-values were in significant negative correlation with medial elastin content and medial smooth muscle cell (SMC) density in thoracic aorta and in positive correlation with the free cholesterol content in abdominal aortic SMC. On the other hand, they were not correlated with either the cross-sectional area of intimal thickening lesions or the plasma lipid levels measured simultaneously. The femoral PWVs were, like those in the aorta, higher in the control group as compared with the normal group, and the changes were improved with administration of EPA-E. These results show that EPA-E improved the in vivo distensibility of arteriosclerotic arteries in HCD-fed rabbits.(ABSTRACT TRUNCATED AT 250 WORDS)
Sato
M
M
Fuji Central Research Laboratory, Mochida Pharmaceutical Company, Gotemba, Japan.
Katsuki
Y
Y
Kanehiro
H
H
Iimura
M
M
Akada
Y
Y
Mizota
M
M
Kunihiro
Y
Y
D000284:Administration, Oral; D000818:Animals; D001011:Aorta / Q000187:drug effects* / Q000473:pathology; D001162:Arteriosclerosis Obliterans / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D002791:Cholesterol, Dietary / Q000494:pharmacology*; D004195:Disease Models, Animal; D015118:Eicosapentaenoic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D005263:Femoral Artery / Q000187:drug effects* / Q000473:pathology; D008055:Lipids / Q000097:blood; D008297:Male; D011817:Rabbits
D002791:Cholesterol, Dietary; D008055:Lipids; C035276:eicosapentaenoic acid ethyl ester; D015118:Eicosapentaenoic Acid